文献速递慢性肾脏病血液净化与透析肾移植

微小RNA-145与微小RNA-486是血管钙化的潜在血清生物标志物

MicroRNA-145 and microRNA-486 are potential serum biomarkers for vascular calcification.
PubMed 文献 · Nephrol Dial Transplant · 2023-01-01

该研究分四阶段:对大鼠钙化与非钙化主动脉行微小RNA测序,并在大鼠主动脉与血清、肾移植供受者腹壁下动脉及一般人群血清中验证候选微小RNA;再将血管平滑肌细胞暴露于不同磷浓度并过表达微小RNA-145与微小RNA-486。结果显示两者与血管钙化负相关,血清微小RNA-145是血管钙化的良好生物标志物,并调控血管平滑肌细胞的成骨分化。

要点

  • 大鼠钙化主动脉中微小RNA-145、微小RNA-122-5p、微小RNA-486与微小RNA-598-3p降低,但血清仅检出微小RNA-145与微小RNA-486。
  • 肾移植受者腹壁下动脉的微小RNA-145与微小RNA-486低于供者,且与动脉钙含量及血管钙化(Kauppila指数)呈负相关。
  • 一般人群中严重血管钙化与两种微小RNA血清水平最低相关,血清微小RNA-145是血管钙化的良好生物标志物。

核心结论

  • 微小RNA-145与微小RNA-486调控血管平滑肌细胞的成骨分化,其在血清中的定量检测可作为血管钙化的标志物。

研究设计与样本

  • 研究分四阶段:阶段1对大鼠钙化与非钙化主动脉行微小RNA测序;阶段2在大鼠主动脉与血清中验证变化率最高的微小RNA及miR-145(血管平滑肌细胞中最丰富的微小RNA);阶段3分析肾移植供者与受者腹壁下动脉及一般人群血清样本;阶段4将血管平滑肌细胞暴露于不同磷浓度并过表达miR-145与miR-486以探究其在血管钙化中的作用。

主要发现

  • 大鼠钙化主动脉中miR-145、miR-122-5p、miR-486与miR-598-3p降低,但血清中仅检出miR-145与miR-486。
  • 人腹壁下动脉中,肾移植受者的miR-145与miR-486低于供者;两者均与动脉钙含量及血管钙化(Kauppila指数)呈负相关。
  • 一般人群中,严重血管钙化与两种微小RNA血清水平最低相关;受试者工作特征曲线显示血清miR-145是血管钙化的良好生物标志物。
  • 血管平滑肌细胞暴露于高磷时,钙含量与成骨标志物(Runx2与Osterix)增加,收缩标志物(α-肌动蛋白)、miR-145与miR-486降低。
  • 过表达miR-145(miR-486程度较轻)可阻止高磷诱导的钙含量增加、成骨分化及收缩表型丢失。

临床怎么用

  • 原文结论认为血清miR-145与miR-486的定量检测可作为血管钙化的标志物,原文未据此给出具体临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: MicroRNAs (miRs) regulate vascular calcification (VC), and their quantification may contribute to suspicion of the presence of VC. METHODS: The study was performed in four phases. Phase 1: miRs sequencing of rat calcified and non-calcified aortas. Phase 2: miRs with the highest rate of change, plus miR-145 [the most abundant miR in vascular smooth muscle cells (VSMCs)], were validated in aortas and serum from rats with and without VC. Phase 3: the selected miRs were analyzed in epigastric arteries from kidney donors and recipients, and serum samples from general population. Phase 4: VSMCs were exposed to different phosphorus concentrations, and miR-145 and miR-486 were overexpressed to investigate their role in VC. RESULTS: miR-145, miR-122-5p, miR-486 and miR-598-3p decreased in the rat calcified aortas, but only miR-145 and miR-486 were detected in serum. In human epigastric arteries, miR-145 and miR-486 were lower in kidney transplant recipients compared with donors. Both miRs inversely correlated with arterial calcium content and with VC (Kauppila index). In the general population, the severe VC was associated with the lowest serum levels of both miRs. The receiver operating characteristic curve showed that serum miR-145 was a good biomarker of VC. In VSMCs exposed to high phosphorus, calcium content, osteogenic markers (Runx2 and Osterix) increased, and the contractile marker (α-actin), miR-145 and miR-486 decreased. Overexpression of miR-145, and to a lesser extent miR-486, prevented the increase in calcium content induced by high phosphorus, the osteogenic differentiation and the loss of the contractile phenotype. CONCLUSION: miR-145 and miR-486 regulate the osteogenic differentiation of VSMCs, and their quantification in serum could serve as a marker of VC.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Fernández-Villabrille S, Martín-Carro B, Martín-Vírgala J, et al. MicroRNA-145 and microRNA-486 are potential serum biomarkers for vascular calcification. Nephrol Dial Transplant. 2023. PMID: 36722155. doi:10.1093/ndt/gfad027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。